ResMed (ASX:RMD) revenue up 12% despite supply chain costs

Latest Company News - Finance News Network

English - January 28, 2022 00:35 - 1000 KB
Business News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Stocks of the Hour: ResMed, Newcrest Mining & PointsBet

Next Episode: Imugene (ASX:IMU) reports on two vaccines

28 Jan 2022 - ResMed (ASX:RMD) increased its revenue by 12% in the December quarter driven by high demand for its sleep and respiratory care products.